Programação

30 de outubro - domingo

7h30-8h Introduction Jatin Shah
8h-9h30 Oral Cancer Moderator: Ashok Shaha
8h-8h30 Oral Cancer Jatin Shah
9h30-8h Panel Discussion Ferris, Lee/Brizel,Bradford, 3 regional experts
9h30-10h Coffee Break
10h-12h Thyroid Cancer Moderator: Robert Ferris
10h-10h30 Treatment of Primary Cancers Jatin Shah
10h30-11h Treatment of the Neck Ashok Shaha
11h-11h30 Complications of Htyroid Surgery Claudio Cernea
11h30-12h Panel Discussion Shaha, Shah, Cernea, Lee/brizel, 3 regional experts
12h-1h30 Lunch  
1h30-4h Multidisciplinary Therapy Moderator: Lisa Licitra
1h30-2h Radiation Therapy Nancy Lee/ David Brizel
2h-2h30 Systemic Therapy Lisa Licitra
2h30-3h Complications from RT Nancy Lee/ David Brizel
3h-4h Panel Discussion Lee/Brizel, Ferris, Bradford, 3 regional experts
4h30-5h45 Salivary Tumors Moderator: Claudio Cernea
4h30-5h Salivary Tumors Ashok Shaha
5h-5h45 Painel Discussion Ferris, Bradford, licitra, 2 regional experts
5h45-7h Operative Techniques in head & Neck Surgery I Jatin Shah, Ashok Shaha, Robert Ferris, Claudio Cernea, Carol Bradford

31 de outubro - segunda-feira

10:30-12:30 Larynx Preservation Moderator: Nancy Lee/David Brizel
10:30-10:50 Endoscopic Surgery for Laryngeal Cancer Robert Ferris
10:50-11:10 Radiation Therapy for Laryngeal Cancer Nancy Lee/ David Brizel
11:10-11:30 Chemotherapy for Laryngeal Cancer Lisa Licitra
11:30-12:30 Panel Discussion (Bradford, Licitra, 3 regional experts)
12:30-1:30 Lunch
1:30-3:00 Stump the Faculty Moderator: Ashok Shaha
1:30-3:00 Panel Discussion (Bradford, Ferris, Lee/Brizel, Cernea, 3 regional experts)
3:00-3:30 Coffee Break
3:30-4:45 Reconstructive Surgery Moderator: Jatin Shah
3:30-4:00 Reconstructive Techniques Carol Bradford
4:00-4:45 Panel Discussion (Ferris, Bradford, Cernea, 3 regional experts)
4:45-6:00 Operative Techniques in Head & Neck Surgery: Part II Jatin Shah, Ashok Shaha, Robert Ferris, Claudio Cernea, Carol Bradford

01 de novembro - terça-feira

8:00-9:30 Oropharyngeal Tumors Moderator: Carol Bradford
8:00-8:30 HPV Positive Disease Robert Ferris
8:30-9:30 Panel Discussion (Cernea, Ferris, Lee/Brizel, Shaha, Licitra, 2 regional experts)
9:30-10:00 Coffee Break
10:00-10:30 Melanoma Moderator: Claudio Cernea
10:00-10:30 Cutaneous Melanoma Carol Bradford
10:30-12:30 Skull Base Surgery Moderator: Robert Ferris
10:30-11:00 Skull Base Surgery Jatin Shah
11:00-12:00 Panel Discussion on Skull Base and Melanona (Bradford, Shah, Lee/Brizel, Ferris, 2 regional experts)

Jatin P. Shah

MD, PhD (Hon.), DSc (Hon), FACS, FRCS (Hon.), FDSRCS (Hon.), FRACS (Hon.), FRCSDS (Hon) Professor Jatin Shah is an international leader who holds The Elliott W. Strong Chair in Head and Neck Oncology at Memorial Sloan Kettering Cancer Center in New York City.

Professor Shah has served as President of The New York Cancer Society, The New York Head and Neck Society, The Society of Head and Neck Surgeons, The North American Skull Base Society, and the International Academy of Oral Oncology. He is Founder and CEO of The International Federation of Head and Neck Oncologic Societies (IFHNOS).

Professor Shah has been the recipient of numerous awards from all continents and is an honorary member of several head and neck societies in Europe, Asia, Australia and South America. He serves on the Editorial and Review Boards of 18 scientific journals and has published more than 500 peer-reviewed publications, 78 book chapters and 10 books. His textbook of Head and Neck Surgery and Oncology won First Prize from The British Medical Association and The Royal Society of Medicine, and was awarded the George Davey Howells Prize from the University of London for the best published book in otolaryngology in the preceding five years. He is a much sought-after speaker who has delivered 87 named lectures and keynote addresses and over 1,200 scientific presentations in 49 countries. In recog- nition of his outstanding contributions and world leadership in head and neck surgery, Memorial Sloan Kettering Cancer Center has established an endowed Chair in his name, the American Head and Neck Society has named an annual symposium in his honor, and the IFHNOS has established an eponymous lecture in his name at its World Congresses.

Ashok R. Shaha

Professor Ashok Shaha is an Attending Surgeon on the Head and Neck Service at Memorial Sloan Kettering Cancer Center, Professor of Surgery at Cornell University Medical College, and holds the Jatin Shah Chair in Head and Neck Surgery at MSKCC. Dr. Shaha completed his surgical training at M.S. University of Baroda and at The Tata Memorial Hospital in India. He completed his surgical training at Downstate Medical Center in Brooklyn, New York and a fellowship in head and neck surgery at Memorial Hospital. He joined the Department of Surgery at Downstate Medical Center in 1982 as a Head and Neck Surgeon, rising to the rank of Professor of Surgery in 1992. During this period, he was also Chief of Head and Neck Surgery at King’s County, Brooklyn VA Hospital and University Hospital. He joined the full time faculty of MSKCC in 1993.

Dr. Shaha has been awarded many honors throughout his career. He has served as President of the New York Head and Neck Society, the American Society for Surgeons of Indian Origin, the Brooklyn Surgical Society, the New York Cancer Society, the New York Surgical Society, the American Head and Neck Society, and the American Association of Endocrine Surgeons. His CV includes more than 500 publications. Dr. Shaha has dedicated his professional career to the training of medical students, residents and fellows. He is Chairman of the Advanced Training Council for Head and Neck Surgery and Oncology Fellowships in the USA.

Carol Bradford

Dr. Carol Bradford serves as chair of the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan Medical School and the Charles J. Krause, M.D., Collegiate Professor of Otolaryngology. She is an internationally recognized leader in the treatment of head and neck cancer.

Dr. Bradford specializes in head and neck cancer surgery and reconstruction, as well as cutaneous oncology and sentinel lymph node biopsy. Her research focuses on identifying and evaluating biomarkers that can predict outcomes in head and neck cancer patients and developing therapies to combat certain types of head and neck cancer that are resistant to traditional forms of treatment. Bradford has published more than 200 peer-reviewed articles.

During her 16-year tenure as co-director of the Head and Neck Oncology Program at the U-M Comprehensive Cancer Center, she helped to advance it from a small program with a few members to one with 30 members from 10 departments and five schools. She continues to play an active role within the program. Bradford is the honored recipient of several awards, including the Jeanne Cady Solis Award for American Medical Women’s Association Mentor- ship and the 2009 Physician of the Year Award from Castle Connolly. More recently, she was elected into the prestigious Institute of Medicine.

Bradford has been an active member of the American Head and Neck Society since 1994. She served as President of this Society from 2011-2012. In addition, she has served as a Trustee of the American Head & Neck Society Foundation (2008-2012), Chair of the Finance Committee (2003-2004), member of the Advanced Training Council (2002-2008), council member (2002-2005) and member of the Finance Committee (2000-2004). She is presently serving on the Board of Directors of the American Academy of Otolaryngology-Head and Neck Surgery.

Nancy Lee

Dr. Nancy Lee is a member, and the Vice Chair of department of radiation Oncology, experimental therapeutics at Memorial Sloan Kettering Cancer Center, where she leads the Selective Mechanistic Augmentation of Radiation Therapy (SMART) Group. Dr. Lee also serves as the Medical director and President of the New York Proton Consortium in New Jersey.

Dr. Lee received her medical degree from New Jersey Medical School. She completed her residency in 2000 at the department of Radiation oncology at Columbia Presbyterian Center at the New York Presbyterian Hospital in New York. In 2003, Dr. Lee joined faculty at the Memorial Sloan-Kettering Cancer Center. She is currently the chief of head and neck cancer at the department of radiation oncology of Memorial Sloan-Kettering Cancer Center.

Dr. Lee has been a lead principle investigator for several national RTOG protocols and a recipient of many awards throughout her career. She has many peer-reviewed publications, chapters, and books.

Claudio R. Cernea

Professor Claudio R. Cernea is Professsor of Surgery of the Department of Head and Neck Surgery of the University of São Paulo Medical School, in São Paulo, Brazil. He is also and Attending Surgeon of Hospital Das Clínicas of the University of São Paulo Medical School, in São Paulo, Brazil.

Professor Cernea has served as President of the Brazilian Society of Head and Neck Surgery, as well as a member of its Executive Council. In addition, he also served as a member of the Executive Council of the American Head and Neck Society, and he served as a member of the Executive Council of IFHNOS, where he is presently Treasurer.

Professor Cernea has published more than 160 peer-reviewed papers, 42 book chapters and 4 books. Some of his most importante publications are related to the surgical classification of the external branch of the superior laryngeal nerve, as well as a surgical maneuver to detect chyle leak during neck dissections. He was the Chief Editor of the book “Pearls and Pitfalls in Head and Neck Surgery”, which offers several practical surgical tips in Head and Neck Surgery and was publisged in English, Portuguese and Mandarin. He received several scientifical awards. He also acted as Visiting Professor in some of the most prestigious Institutions of the world; for example: Harvard Medical School, Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Johns Hopkins Medical School, University of Hong Kong, Albert Einstein College of Medicin, Baylor College at Dallas, University of Pennsylvania, University of Göt- tingen, Free University at Amsterdam, Universitá Católica di Roma and University of Pittsburgh, among many others. He has delivered several key note lectures and conferences in meetings around the world, as well as over 400 scientific presentations in national and international meetings.

Robert L. Ferris

Dr. Robert Ferris completed his training at Johns Hopkins, focused on head and neck oncologic surgery and cancer immunology. He moved to the University of Pittsburgh Department of Otolaryngology in 2001, where Dr. Ferris is currently the UPMC Endowed Professor, Vice-Chair and Chief of Head and Neck Surgery, and Fellowship Director in Head and Neck Oncologic Surgery. At the University of Pittsburgh Cancer Institute, he is Co-Leader of the Cancer Immunology Program and Associate Director for Translational Research. Dr. Ferris serves on the Editorial Boards of JNCI, Clinical Cancer Research, Cancer Immunology Research and Section Editor for Cancer, Oral Oncology, and Head and Neck. Dr. Ferris has published over 200 peer-reviewed manuscripts and was recently elected co-chair of the NCI Head and Neck Steering committee to facilitate prospective clinical trials.

Dr. Ferris’s NIH-funded laboratory is focused on reversal of immune escape and immunotherapy using monoclonal antibodies and cellular vaccines. Dr. Ferris is leading several prospective randomized trials, including ECOG 3311, testing radiation dose-deintensification after transoral robotic surgery (TORS) for HPV+ oropharynx cancer, and several randomized phase II-III trials of anti-PD-1 and anti-CTLA-4 immunotherapy. He is Princi- pal Investigator of the University of Pittsburgh Specialized Program of Research Excellence (SPORE) grant for translational head and neck research, and a T32 training grant, “Training of Head and Neck Oncologists,” both funded by the National Cancer Institute until 2020. Dr. Ferris has authored numerous book chapters and co-edited two textbooks, Salivary Gland Disorders and Master Techniques in Head and Neck Surgery.

David M. Brizel

Professor David Brizel is co-Director of the Head and Neck Cancer Program at the Duke Cancer Institute. He holds the Leonard Prosnitz Chair in Radiation Oncology and is also a Professor in Surgery at Duke University Medical Center. He joined the faculty at Duke after completing his residency at the Harvard Joint Center for Radiation Therapy in 1987.

Dr. Brizel’s research has focused on several areas related to head and neck cancer: concurrent chemoradiation for advanced stage disease, radioprotective strategies to reduce toxicity, tumor hypoxia as a therapeutic target, and functional metabolic imaging for adaptive treatment planning. Dr. Brizel has served as an invited speaker and visiting professor at many institutions around the world. He has published more than 125 peer reviewed articles and book chapters. He has worked on the editorial boards of Radiation Research and the Journal of Clinical Oncology. He is a co-editor of the head and neck section of Up to Date Oncology.

Dr. Brizel served 5 years on the National Cancer Institute’s Radiation Therapeutics and Biologics Study Section. In 2014 he completed a 4-year term as co-Chair of the NCI’s Head and Neck Steering Committee, which is charged with the development of phase 2 and 3 cooperative group clinical trials in head and neck cancer. Currently, he co-chairs the Duke Cancer Protocol Review Committee and is co-PI of the Duke site in its role in the NCI’s National Clinical Trials Network. Dr Brizel has also been a member of the National Comprehensive Cancer Center’s Head and Neck Committee since 2002.

Lisa Licitra

Lisa Licitra is Board-certified in medical oncology, with special expertise in the treatment of head and neck cancers. She is currently assistant physician in charge of the Head and Neck Cancer Medical Oncology Unit at the Istituto Nazionale Tumori in Milan, Italy.

Dr. Licitra is Free-contract Professor at State University of Milan, a member of the Clinical Editorial Board of the Journal of Clinical Oncology,Editor of START - State-of-the-Art Oncology in Europe (www.startoncology.net) a project of Alleanza Contro il Cancro – Ministry of Health - Italy, a reviewer of the PDQ Summaries on head and neck cancers, a Board Member of EORTC and European Organization for the Research and Treatment of Cancer and Elected Chair of Head and Neck Cancer Cooperative Group of EORTC, co-founder and member of IGEO - Italian Group for the Evaluation of Outcomes in Oncology, Member of The Educational Committee of ESMO (European Society for Medical Oncology), Chair of the Head and Neck Faculty of ESMO, Co-founder and member, as medical oncologist, for the European Head and Neck Cancer Society, a member of the American Society for Clinical Oncology (ASCO), a mem- ber of the Italian Association for Medical Oncology (AIOM) and honorary member of the European Society for Therapeutic Radiolog and Oncology (ESTRO). Recently Awarded with the “Guido Venosta” Prize of the Italian Foundation for Cancer Research.

Her main fields of interest are head and neck neoplasms, evidence-based medicine, clinical methodology in oncology, and quality of life. Dr Licitra has written five book chapters and approximately 70 scientific articles.

Corpo Clínico

Conheça os profissionais que fazem parte do curso

Valores em Real

Categoria

16/01 a 26/04

27/04 a 30/06

01/07 a 20/10

Local

MÉDICO SÓCIO - SBCCP

850,00

1.050,00

1.250,00

1.500,00

MÉDICO NÃO SÓCIO

1.600,00

1.800,00

1.980,00

2.200,00

RESIDENTE - SÓCIO - SBCCP

450,00

510,00

670,00

850,00

RESIDENTE - NÃO SÓCIO - SBCCP

750,00

900,00

1.000,00

1.200,00

Valores em dólar

Categoria

16/01 a 26/04

27/04 a 30/06

01/07 a 20/10

Local

MÉDICO SÓCIO - SBCCP

243

300

358

430

MÉDICO NÃO SÓCIO

458

515

565

630

RESIDENTE - SÓCIO - SBCCP

130

145

192

250

RESIDENTE - NÃO SÓCIO - SBCCP

215

258

285

350

Faça sua inscrição

Preencha o formulário